Way With Words Offline Assessment Audio Mixed Accents
Speaker Key:
SP Speaker SP1 And the other thing is someone of our investors have an issue with pace. So, investment pace is… SP2 They have an issue with what?SP1 Investment pace. Now that is, is the number of days… The timeline for when you have allowed your deals. Because depending on who the investors are, some of them wants you to spend the money very quickly and others want you to be prudent.So we’ve done two deals. So our next… We’ve probably one more deal to do this year at the most. And the first two deals, one is American, and it’s company called Chrono. And we are core-invested with 5AM Ventures and Kayman and some other parties.And it’s really indicative [?] advance nicotine delivery, back to your egalite days.It’s very much specialty pharma.SP1 And it’s stuff from our land days [?]. We understand that whole chrono biology well. And it’s almost into the quasi consumer but it’s still on the prescription- based side.SP2 Right.SP1 But getting close to that… In our portfolio assembly, we were told to do something that was in that IT… Health IT space. So, the second deal we’ve done is one which is an Irish company.And it went IPO. It was led by Sofinnova Ventures. And I think you had been talking to them about Adenium [?] when we spoke previously. So, we’ve done two deals basically with Sofinnova Ventures.And that’s Innocoll [?] and its again speciality pharma and collagen-based pain and sort of slow-release technology for use in surgery and riding the wave of the need to replace narcotic analgesics.SP2 Okay.SP1 So, there are sort of two deals done. If we are going to do another deal this year, it is time to do an already stage one because we would have the timeline to do some investing. Okay?SP2 Okay.SP1 All is back on the table. We have two or three different deals again back in the mix. So, my job here is to try and get an update on Adenium to see if its still one of the ones that we will consider for this year and if so, on what basis and where are you?
- / 1